Nimotuzumab Combined With the Stupp Regimen for Postoperative Residual Glioblastoma
Clinical trial NCT07707973 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07707973
- Sponsor
- Tianjin First Central Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-07-03
- Primary completion
- 2028-01-03
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.